Insulin Receptor anticorps (pTyr1135, pTyr1150)
Aperçu rapide pour Insulin Receptor anticorps (pTyr1135, pTyr1150) (ABIN2987232)
Antigène
Voir toutes Insulin Receptor (INSR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr1135, pTyr1150
-
Purification
- Affinity purified
-
Immunogène
- Synthetic Peptide. A phospho specific peptide corresponding to residues surrounding Y1189 of human Insulin Receptor beta.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.02 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
- Insulin Receptor (INSR)
-
Autre désignation
- INSR
-
Poids moléculaire
-
Calculated MW: 154 kDa/155 kDa/156 kDa
Observed MW: 80 kDa -
ID gène
- 3643
-
UniProt
- P06213
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, AMPK Signaling, Carbohydrate Homeostasis, Regulation of Cell Size, Regulation of Carbohydrate Metabolic Process, Growth Factor Binding, Negative Regulation of Transporter Activity
Antigène
-